from this laboratory (1) (9) , and others (10, 11) permit rapid and reliable quantitative identification of barbiturate compounds in the blood and urine. Studies of nonfatal barbiturate intoxications (2) (3) (4) (5) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) have only reported the initial blood barbiturate levels found at the time of the patient's admission to the hospital.
In only some few cases (4, 5, 12, 18 ) are several successive blood barbiturate levels reported from the same hospitalized patient. These studies indicate that there probably is a direct correlation between the patient's clinical condition and the blood barbiturate level. This study presents additional data to support this thesis.
MATERIAL AND METHODS
The data presented in this study were obtained from 44 patients who were admitted to several hospitals in this vicinity because of barbiturate intoxication.
Samples The deep tendon reflexes were used as the criteria for the presence of reflexes. Corneal, pupillary, and abdominal responses are subject to more variability in relation to the levels of anesthesia. Gag and cough reflexes return at about the same time as the deep tendon reflexes; response to pain returns later. The respiratory difficulty in Stage V is due to direct depression of the medullary respiratory center and is not due to the secondary pneumonia which often develops in these patients. All barbiturates were qualitatively and quantitatively determined, using a slight modification of Goldbaum's technic (8) . The modification is in the adjustment of the 0.45N NaOH extract of the barbiturate to pH 10.5. This is accomplished by adding 0.5 ml. of 16% NH4C1 to the 3 ml. of O.45N NaOH in the Beckman cuvet. The resulting mixture has the required pH and can then be read directly (19) . Duplicate determinations using this technic checked within 10 per cent. All barbiturate levels are reported as the sodium salts of the respective barbituratic acid. Whenever possible, the qualitative identification of the barbiturate derivative was confirmed by melting-point determinations, micro crystalline appearances or, more recently, paper chromatographic technics (20) (21) (22) .
Since the amount of drug taken and the time of ingestion could only be ascertained by anamnestic data of questionable reliability, these data are not presented in this study. Consequently, all times mentioned throughout the discussion are based on the period between a given observation and the moment the patient was &lmitted to the hospital.
RESULTS
A previous paper by the authors (18) presented some data on the correlation of a patient's clinical condition following phenobarbital ingestion with his blood phenobarbital level. The phenobarbital data are supple-mented and included in the current study (Tables 1-4 ). The number of patients studied is large enough to make conclusions from the data statistically reliable. Table 1 corroborates the authors' previous findings with respect to phenobarbital intoxication. Data by other investigators (2-5) also agree that recovery from phenobarbital intoxication occurs when the blood phenobarbital level is 4.0-5.5 mg. per 100 ml. Stage II, the ability of the patient to respond to questions, even if lethargic and sleepy, is the criterion of recovery that is used throughout this discussion. 
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"The blood levels represent that point where the patients entered a given clinical stage. Table 2 presents the findings in cases of amobarbital intoxication. The blood amobarbital level at which recovery was noted was in the range of 2.0-2.5 mg. per 100 ml. Severe intoxication was always noted if the blood amobarbital level was higher than 5.5-6.0 mg. per 100 ml., the recovery level for many phenobarbital-intoxicated patients. This serves to emphasize the need for qualitative, as well as quantitative, chemical analysis in all cases of barbiturate intoxication. In any given individual, the severity of the intoxication is a function, among other factors, of not only how much, but also, which barbiturate compound was ingested. 
129
This thesis is further substantiated by the data in Tables 3 and 4 . In the cases of pentobarbital and secobarbital, patients recovered with blood barbiturate levels ranging from 1.5-2.5 mg. per 100 ml. and 1.2-1.7 mg. per 100 ml., respectively. Severe intoxication was noted whenever the blood barbiturate levels were higher than 3.5 mg. per 100 ml. It is interesting to note that according to their respective blood barbiturate levels, 3 patients, M. B. in Table 3 and C. G. and R. W. in Table 4 , were more sedated than the average. Anomalous results might be expected in any individual as a result of tolerance, a pathologic condition, or the presence of other chemical agents. In these three cases, the atypical data are probably due to the simultaneous presence of ethyl alcohol. This synergism between ethanol and the barbiturates has been documented previously (23, 24) .
A summary of all the data on the blood barbiturate level as a function of a patient's clinical condition is presented in Table 5 . The data obtained by other investigators in this field are consistent with those in the summary. Chemical analyses are being used more frequently to confirm the clinical diagnosis of barbiturate intoxication. Whenever a positive chemical analytical result is obtained, the invariable question to be answered is how long it will take for the patient to recover from his barbiturate intoxication, presuming no other complications supervene. Figures 1-4 help answer this question. Since the data are linear on the semilogarithmic coordinate system, the decrease in blood barbiturate concentration is exponentially related to the time elapsing following ingestion.
Half-Life of Barbiturates
On the basis of these data, the half-life of the several barbiturates can be calculated. (The half-life is that period of time required for the blood level to fall to half its original value.) Another instructive calculation is the percentage fall in a given blood level in one day. Both the results are presented in Table 6 .
As one would expect, the half-life and the percentage of daily decrease of the barbiturate level are a direct function of the duration of action of these agents as recognized clinically. The longer-acting barbiturates have a longer half-life and lower percentage of daily decrease than do the shorter-acting barbiturates.
Lous presented similar data on the daily Urine barbiturate levels are frequently requested by clinicians as a diagnostic aid. Urinary barbiturate analysis indicates only that a barbiturate is being excreted and is not an indication of the degree of his central nervous system depression. It may help in the qualitative identification of the barbiturate implicated. However, this is all one can or should expect from such a determination.
Renal Clearances
Since renal excretion is one way the body disposes of chemical agents, data were accumulated on the urinary excretion of barbiturates. Figures  5-7 show the renal clearances of barbiturates as a function of the rate of urine flow. These data indicate that the clearance is greater at higher urine flows. No leveling off of the curves was noted at higher urine flows. URINE ROW ml. ,min. Lous (2) studied renal clearances of phenobarbital and barbital. He found that these renal clearances increased from two to four times as the urine flow rate is raised from 0.5 ml./min. to 4 mI./min. No appreciably further rise in clearance values were noted at higher urine flow rates. The data in this study confirm Lous' first conclusion. No urine flow rates higher than 4 ml./min., were attained in any patient in this study. No comment can be made, therefore, on Lous' second conclusion.
Total Barbiturate Excretion
The total amount of barbiturates excreted daily in the urine was never very high. Actual amounts varied from 50 to 60 mg./day in the shortacting barbiturates to 180 mg./day for the longer-acting ones. Only in the case of barbital did this urine excretion seem significant. In the one case studied, 6 Gm. were excreted in a 5-day period! The other data obtained in this one barbital case are recorded in Table 7 . 4 7.95
DISCUSSION
The data presented in Tables 1-4 indicate that there is a reasonably acceptable correlation between a patient's clinical condition and his blood barbiturate level. There is a sufficiently small variation in each range so that the data in Table 5 represent average values that one can use to interpret the results of a single quantitative chemical analysis. In general, a patient with a blood phenobarbital level of less than 6.0 mg. per 100 ml., a blood amobarbital level of less than 4.5 mg. per 100 ml., or a blood pentobarbital or secobarbital level of less than 2.5 mg. per 100 ml. will not be seriously ill due to the barbiturate alone. Although he may be comatose, reasonably conservative therapy (25) is all this patient requires.
Potentiation of the effects of the barbiturate by other drugs may occasionally confuse the clinical picture. The authors have seen several cases of concurrent ingestion of ethanol and a barbiturate and one case of simultaneous chiorpromazine-barbiturate ingestion. In all these cases, the patients were much more depressed than one would expect from the barbiturate alone. When a patient appears more depressed than would be expected from the blood barbiturate level, one should always investigate the possibility of concurrent intoxication with other chemical agents. Trauma may also be a factor in some of these atypical cases. The presence of intracranial lesions will deepen the depression due to a given dose of a barbiturate.
However, physical examination will usually reveal the presence of these conditions.
Tolerance will also give atypical data. The authors have discussed the problem in more detail elsewhere (26) . They presented eight cases in which evidence was found, clinically and chemically, of tolerance to phenobarbital.
Such patients, with blood phenobarbital levels of 7-8 mg. per 100 ml. were competent and awake. Isbell (27) , Lous (11) , and
